Figuring out what you might pay out-of-pocket for a vaccination can be confusing. What you pay will depend on many factors, including your insurance situation and if there are financial support options available to you. At Merck, we believe that you should be better able to understand what you can expect to pay out of your own pocket for your shot.
The list price for each indicated dose of GARDASIL 9 is $286.78. a Most people will not pay the list price, although it may have an impact on your out-of-pocket costs. b The amount you pay will depend on many factors, including your insurance situation. The information below will help you better estimate what you may pay for your vaccination based on your insurance situation. c For the actual out-of-pocket cost of your vaccine, talk to your insurance provider, who knows the details of your plan if you have insurance, or contact your health care provider’s office for help.
GARDASIL 9 is a shot that is usually given in the arm muscle. GARDASIL 9 may be given as 2 or 3 shots.
The appropriate dosing schedule will be determined by your health care professional.
a The list price is current as of August 2023. The list price does not include vaccine administration fees.
b The out-of-pocket costs include the price patients paid for GARDASIL 9.
c The out-of-pocket costs below do not include costs associated with administration of GARDASIL 9.
For patients with commercial insurance, 98.7% of patients paid no out-of-pocket costs for a shot of GARDASIL 9. For those patients who did have out-of-pocket costs, 80% of patients paid between $0.01 and $322 for a shot of GARDASIL 9. ¹
¹ IQVIA GARDASIL 9 OOP Costs, August 2023. Based on an analysis of September 2022 to August 2023 commercial, Medicare, and IQVIA Medicaid claims. Commissioned by Merck Sharp & Dohme LLC. IQVIA’s analysis is based on remittance data that provide claim payment information after medical claims have been processed by the patient’s medical insurer and assigned to primary payer channel. The data are limited to remittance transactions on medical claims collected by IQVIA and may not constitute a nationally representative sample. Please note that a patient’s cost may differ from the amounts depicted above.
Vaccination in pharmacy I have commercial insurance through an employer or private policy that covers GARDASIL 9.For patients with commercial insurance, 92.3% of patients paid no out-of-pocket costs for a shot of GARDASIL 9. For those patients who did have out-of-pocket costs, 80% of patients paid between $0.01 and $290 for a shot of GARDASIL 9. ¹
¹IQVIA™: OPC Provider for the period September 2022 to August 2023 reflecting real-world claims activity for administration from retail pharmacies for which data are available in the IQVIA™: OPC Provider database. Reported ranges are based on actual final patient out-of-pocket costs (for commercially insured patients) for patients vaccinated with GARDASIL 9. Reported ranges include both paid and reversed claims for vaccinations for which data are available. All out-of-pocket cost values are based on a single shot of GARDASIL 9. Data accessed as of August 2023. All rights reserved.
For patients with Medicare coverage, 96.1% of patients paid no out-of-pocket costs for a shot of GARDASIL 9. For those patients who did have out-of-pocket costs, 80% of patients paid between $0.01 and $290.45 for a shot of GARDASIL 9.¹
¹IQVIA GARDASIL 9 OOP Costs, August 2023. Based on an analysis of September 2022 to August 2023 commercial, Medicare, and Medicaid claims. Commissioned by Merck Sharp & Dohme LLC. IQVIA’s analysis is based on remittance data that provide claim payment information after medical claims have been processed by the patient’s medical insurer and assigned to primary payer channel. The data are limited to remittance transactions on medical claims collected by IQVIA and may not constitute a nationally representative sample. Please note that a patient’s cost may differ from the amounts depicted above.
Vaccination in pharmacy I have coverage for GARDASIL 9 through Medicare.For patients with Medicare Part D coverage, 82.9% of patients paid no out-of-pocket costs for a shot of GARDASIL 9. For those patients who did have out-of-pocket costs, 80% of patients paid between $0.01 and $270 for a shot of GARDASIL 9. ¹
¹IQVIA™: OPC Provider for the period September 2022 to August 2023 reflecting real-world claims activity for administration from retail pharmacies for which data are available in the IQVIA™: OPC Provider database. Reported ranges are based on actual final patient out-of-pocket costs for patients vaccinated with GARDASIL 9. Reported ranges include both paid and reversed claims for vaccinations for which data are available. All out-of-pocket cost values are based on a single shot of GARDASIL 9. For Medicare, low income subsidy patients are included in out-of-pocket cost calculations. Data accessed as of August 2023. All rights reserved. Please note that a patient’s cost may differ from the amounts depicted above.
Vaccination in doctor’s office
I have coverage for GARDASIL 9 through Medicaid.
For patients with Medicaid, 99.7% of patients paid no out-of-pocket costs for a shot of GARDASIL 9.¹ For those patients who did have out-of-pocket costs, 80% of patients paid between $0.01 and $345. To learn more about Medicaid in your state and find out if you’re eligible, visit https://www.medicaid.gov/medicaid-and-you/index.html
¹IQVIA GARDASIL 9 OOP Costs, August 2023. Based on an analysis of September 2022 to August 2023 commercial, Medicare, and Medicaid claims. Commissioned by Merck Sharp & Dohme LLC. IQVIA’s analysis is based on remittance data that provide claim payment information after medical claims have been processed by the patient’s medical insurer and assigned to primary payer channel. The data are limited to remittance transactions on medical claims collected by IQVIA and may not constitute a nationally representative sample. Please note that a patient’s cost may differ from the amounts depicted above.
Vaccination in pharmacy
I have coverage for GARDASIL 9 through Medicaid.
For patients with Medicaid, 99.9% of patients paid no out-of-pocket costs for a shot of GARDASIL 9. For those patients who did have out-of-pocket costs, 80% of patients paid between $0.01 and $290 for a shot of GARDASIL 9 .¹ Your out-of-pocket costs may vary if you have a higher income. To learn more about Medicaid in your state and find out if you’re eligible, visit www.medicaid.gov/medicaid-and-you/index.html
¹IQVIA™: OPC Provider for the period September 2022 to August 2023 reflecting real-world claims activity for administration from retail pharmacies for which data are available in the IQVIA™: OPC Provider database. Reported ranges are based on actual final patient out-of-pocket costs for patients vaccinated with GARDASIL 9. Reported ranges include both paid and reversed claims for vaccinations for which data are available. All out-of-pocket cost values are based on a single shot of GARDASIL 9. For Medicare, low income subsidy patients are included in out-of-pocket cost calculations. Data accessed as of August 2023. All rights reserved. Please note that a patient’s cost may differ from the amounts depicted above.
I don’t have insurance, or GARDASIL 9 is not covered by my insurance.
If you don’t have insurance coverage or if your insurance does not cover vaccination with GARDASIL 9, you could pay an amount closer to the list price shown above, plus any additional charges depending on where you receive your vaccination.
Brands mentioned are the trademarks of their respective owners.
GARDASIL 9 helps protect individuals ages 9 to 45 against the following diseases caused by 9 types of HPV: cervical, vaginal, and vulvar cancers in females, anal cancer, certain head and neck cancers, such as throat and back of mouth cancers and genital warts in both males and females.
GARDASIL 9 may not fully protect everyone, nor will it protect against diseases caused by other HPV types or against diseases not caused by HPV. GARDASIL 9 does not prevent all types of cervical, vulvar, vaginal, anal, or head and neck cancers.
Vaccination does not remove the need for recommended cancer screenings, and it’s important to get routine cervical cancer screenings. GARDASIL 9 does not treat HPV infection, cancer, or genital warts.
GARDASIL 9 is a shot that is usually given in the arm muscle. GARDASIL 9 may be given as 2 or 3 shots.
The appropriate dosing schedule will be determined by a health care professional.
Anyone with an allergic reaction to the ingredients of GARDASIL 9 or GARDASIL ® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], including those severely allergic to yeast, should not receive the vaccine. GARDASIL 9 was not studied in women who knew they were pregnant.
Fainting can happen after getting GARDASIL 9. Sometimes people who faint can fall and hurt themselves. For this reason, the health care professional may ask the person getting GARDASIL 9 to sit or lie down for 15 minutes after getting the vaccine. Some people who faint might shake or become stiff.
The side effects include pain, swelling, redness, itching, bruising, bleeding, and a lump where you got the shot; headache; fever; nausea; and dizziness.
Only a doctor or health care professional can decide if GARDASIL 9 is right for you.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please read the Patient Information for GARDASIL 9, and discuss it with your doctor. The physician Prescribing Information also is available.